找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Esophageal Cancer; Diagnosis and Treatm Francisco Schlottmann,Lorenzo Ferri,Marco G. Patti Textbook 2023Latest edition The Editor(s) (if ap

[復(fù)制鏈接]
樓主: Strategy
51#
發(fā)表于 2025-3-30 11:06:51 | 只看該作者
52#
發(fā)表于 2025-3-30 15:56:51 | 只看該作者
53#
發(fā)表于 2025-3-30 16:45:13 | 只看該作者
54#
發(fā)表于 2025-3-30 22:38:01 | 只看該作者
55#
發(fā)表于 2025-3-31 02:02:03 | 只看該作者
Asha Humbal,Neha Chaudhary,Bhawana Pathakntly, the potentially reduced quality of life, endoscopic therapy represents a favorable approach where appropriate. Endoscopic resection therapies have been successfully applied to selected patients with early tumors of the esophagus with equivalent oncological outcomes. This chapter will address t
56#
發(fā)表于 2025-3-31 07:11:57 | 只看該作者
Advances in Global Change Researche two diseases entities should be treated differently. It is clear that chemotherapy or chemoradiotherapy should be given before surgery; however, perioperative systemic regimens have taken over the landscape for patients with EAC in many centers around the world. Although significant regional diffe
57#
發(fā)表于 2025-3-31 09:52:14 | 只看該作者
Mohammed H. I Dore,Peter Simciskodiotherapy (dCRT) is at least equivalent to trimodality therapy in terms of long-term survival for patients with esophageal squamous cell carcinoma (ESCC). Frail patients with ESCC who are not fit for surgery should receive dCRT. For those who are considered fit for esophagectomy, decision between d
58#
發(fā)表于 2025-3-31 16:58:09 | 只看該作者
Kenneth D. Frederick,David C. Majorhe biology and the potential role of identifying biomarkers of response, and offers a comprehensive overview of the clinical trials that have evaluated the use of immunotherapy in different settings of the treatment of esophageal cancer.
59#
發(fā)表于 2025-3-31 18:35:32 | 只看該作者
60#
發(fā)表于 2025-4-1 00:13:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 07:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
郎溪县| 丘北县| 余姚市| 岐山县| 明水县| 高雄县| 新野县| 色达县| 方山县| 广昌县| 锡林郭勒盟| 茌平县| 十堰市| 饶阳县| 壤塘县| 增城市| 互助| 盐城市| 许昌市| 长武县| 资阳市| 肇庆市| 柯坪县| 鹤岗市| 扬中市| 无棣县| 工布江达县| 宜昌市| 五华县| 绥芬河市| 巴东县| 芒康县| 墨竹工卡县| 丰镇市| 土默特右旗| 尼玛县| 盈江县| 抚顺市| 和平区| 茌平县| 方城县|